Intranasal Immunization with a Colloid-Formulated Bacterial Extract Induces an Acute Inflammatory Response in the Lungs and Elicits Specific Immune Responses

Infection and Immunity

Volumn 72, Issue 5, 2004, Pages 2679-2688

  Rial, A ^a,c   Lens, D ^c   Betancor, L ^a,d   Benkiel, H ^b   Silva, J S ^e   Chabalgoity, J A ^a  

^a Universidad de la Republica Instituto de Higiene   (Uruguay)

^b Laboratorios IRASA   (Uruguay)

^c Lab de Citometria y Biol Molecular   (Uruguay)

^d DEPARTAMENTO DE BIOQUÍMICA   (Uruguay)

^e UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CHEMOKINE; B7 ANTIGEN; BACTERIAL PROTEIN; BACTERIAL VACCINE; BACTERIUM LIPOPOLYSACCHARIDE; CD86 ANTIGEN; CHEMOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; INTERLEUKIN 10; INTERLEUKIN 12; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIGEN EXPRESSION; ARTICLE; CELL PROLIFERATION; CELL TRANSPORT; COLLOID; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; CYTOKINE PRODUCTION; DENDRITIC CELL; DRUG FORMULATION; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOMODULATION; IMMUNOTHERAPY; INFLAMMATION; LUNG HOMOGENATE; LUNG LAVAGE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, INTRANASAL; ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BASE SEQUENCE; CHEMOKINES; COLLOIDS; CYTOKINES; DENDRITIC CELLS; FEMALE; LUNG; MICE; MICE, INBRED C57BL; NEUTROPHILS; RESPIRATORY TRACT INFECTIONS; RNA, MESSENGER;

EID: 2142807324     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.72.5.2679-2688.2004     Document Type: Article

References (78)

1. Banchereau, J., F. Briere, C. Caux, J. Davoust, S. Lebecque, Y.-J. Liu, B. Pulendran, and K. Palucka. 2000. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18:767-811.
2. Bartlett, J. G., P. O'Keefe, F. P. Tally, T. J. Louie, and S. L. Gorbach. 1986. Bacteriology of hospital-acquired pneumonia. Arch. Intern. Med. 146:868-871.
3. Bellanti, J. A., and B. J. Zeligs. 1994. Current concepts of immune interventions in children with respiratory diseases. Respiration 61(Suppl. 1):3-7.
4. Berman, S. 1995. Otitis media in children. N. Engl. J. Med. 332:1560-1565.
5. Berstad, A. K., F. Oftung, G. E. Korsvold, I. L. Haugen, L. O. Froholm, J. Holst, and B. Haneberg. 2000. Induction of antigen-specific T cell responses in human volunteers after intranasal immunization with a whole-cell pertussis vaccine. Vaccine 18:2323-2330.
6. Berstad, A. K., J. Holst, B. Mogster, I. L. Haugen, and B. Haneberg. 1997. A nasal whole-cell pertussis vaccine can induce strong systemic and mucosal antibody responses which are not enhanced by cholera toxin. Vaccine 15:1473-1478.
7. Bessler, W. G., B. Kleine, C. Martinez Alonso, L. Biesert, M. Strecker, K. H. Wiesmüller, J. Metzger, and G. Jung. 1990. Biological activity of bacterial surface components: bacterial extract and defined bacterial cell wall components as immunomodulators. Lung 168(Suppl.):707-715.
8. Bessler, W. G., M. Huber, and W. Baier. 1997. Bacterial cell wall components as immunomodulators. II. The bacterial cell wall extract OM-85 BV as unspecific activator, immunogen and adjuvant in mice. Int. J. Immunpharmacol. 19:551-558.
9. Brook, I., and A. E. Gober. 1998. Microbiologic characteristics of persistent otitis media. Arch. Otolaryngol. Head Neck Surg. 124:1350-1352.
10. Broug-Holub, E., H. A. Perssons, K. Schornagel, and G. Kraal. 1995. Changes in cytokine and nitric oxide secretion by rat alveolar macrophages after oral administration of bacterial extracts. Clin. Exp. Immunol. 101:302-307.
11. Caux, C., C. Massacrier, B. Vanhervliet, B. Dubois, I. Durand, M. Cella, A. Lanzavecchia, and J. Banchereau. 1997. CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cells pathways in response to granulocyte-macrophage colony-stimulating factor plus tumor necrosis factor γ. II. Functional analysis. Blood 90:1458-1470.
12. Chabalgoity, J. A., C. M. Khan, A. A. Nash, and C. E. Hormaeehe. 1996. A Salmonella typhimurium htrA live vaccine expressing multiple copies of a peptide comprising amino acids 8-23 of herpes simplex virus glycoprotein D as a genetic fusion to tetanus toxin fragment C protects mice from herpes simplex virus infection. Mol. Microbiol. 19:15-23.
13. Chabalgoity, J. A., J. A. Harrison, A. Esteves, R. Demarco de Hormaeche, R. Ehrlich, C. M. Khan, and C. E. Hormaeche. 1997. Expression and immunogenicity of an Echinococcus granulosus fatty acid-binding protein in live attenuated Salmonella vaccine strains. Infect. Immun. 65:2402-2412.
14. Collet, J.-P., P. Shapiro, P. Ernst, P. Renzi, A. Robinson, et al. 1997. Effects of an immunostimulating agent on acute exacerbations and hospitalizations on patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 156:1719-1724.
15. Collet, J.-P., T. Ducruet, M. S. Kramer, J. Haggerty, D. Floret, J.-J. Chomel, F. Durr, et al. 1993. Stimulation of nonspecific immunity to reduce the risk of recurrent infections in children attending day-care centers. Pediatr. Infect. Dis. J. 12:648-652.
16. Collet, J. P., and J. P. Boissel. 1994. OM-85 BV: primary versus secondary prevention. Respiration 61(Suppl. 1):20-23.
17. Cripps, A. W., M. L. Dunkley, G. Pang, and R. L. Clancy. 1994. Mucosal and systemic immunization with killed Pseudomonas aeruginosa protects against acute respiratory infection in rats. Infect. Immun. 62:1427-1436.
18. Cvoriscec, B., M. Ustar, R. Pardon, I. Palecek, A. Stipic-Markovic, and B. Zimic. 1989. Oral immunotherapy of chronic bronchitis: a double blind placebo controlled multicentre study. Respiration 55:129-135.
19. Davis, S. S. 2001. Nasal vaccines. Adv. Drug. Deliv. Rev. 51:21-42.
20. Derenne, J., and B. Delclaux. 1991. Clinical experience with OM-85 BV in upper and lower respiratory tract infections. Respiration 59(Suppl. 3):28-31.
21. de Saint-Vis, B., I. Fugier-Vivier, C. Massacrier, C. Gaillard, B. Vanbervliet, S. Aït-Yahia, J. Banhereau, Y.-J. Liu, S. Lebecque, and C. Canx. 1998. The cytokine profile expressed by human dendritic cells is dependent on cell subtypes and mode of activation. J. Immunol. 160:1666-1676.
22. Dixon, A. E., J. B. Mandac, D. K. Madtes, P. J. Martín, and J. G. Clark. 2000. Chemokine expression in Th1 cell-induced lung injury: prominence of IFN-γ-inducible chemokines. Am. J. Physiol. Lung Cell Mol. Physiol. 279:L592-L599.
23. Emmerich, B., H. P. Emslander, D. Milatovic, M. Hallek, and K. Pachmann. 1990. Effects of a bacterial extract on local immunity of the lung in patients with chronic bronchitis. Lung 168(Suppl.):726-731.
24. Faden, H., J. J. Hong, and N. Pabade. 1994. Immune response to Moraxella catarrhalis in children with otitis media: opsonophagocytosis with antigen-coated latex beads. Ann. Otol. Rhinol. Laryngol. 103:522-524.
25. Fein, A. M. 1999. Pneumonia in the elderly: overview of diagnostic and therapeutic approaches. Clin. Infect. Dis. 28:726-729.
26. Hart, D. N. J. 1997. Dendritic cells: unique leukocyte populations which control the primary immune response. Blood 90:3245-3290.
27. Hirano, T., Y. Hou, X. Jiao, and X. X. Gu. 2003. Intranasal immunization with a lipooligosaccharide-based conjugate vaccine from nontypeable Haemophilus influenzae enhances bacterial clearance in mouse nasopharynx. FEMS Immunol. Med. Microbiol. 35:1-10.
28. Holt, P. G., and P. A. Stumbles. 2000. Regulation of immunological homeostasis in peripheral tissues by dendritic cells: the respiratory tract as a paradigm. J. Allergy Clin. Immunol. 10S:421-429.
29. Holt, P. G., P. A. Stumbles, and A. S. McWilliam. 1999. Functional studies on dendritic cells in the respiratory tract and related mucosal tissues. J. Leukoc. Biol. 66:272-275.
30. Holt, P. G., J. E. Batty, and K. J. Turner. 1981. Inhibition of specific IgE responses in mice by pre-exposure to inhaled antigen. Immunology 42:409-417.
31. Huber, M., K. Krauter, G. Winkelmann, H. W. Bauer, V. W. Rahlfs, P. A. Lauener, G. S. S. Blebmann, and W. G. Bessler. 2000. Immunostimulation by bacterial components. II. Efficacy studies and meta-analysis of the bacterial extract OM-89. Int. J. Immunopharmacol. 22:1103-1111.
32. Hvaibye, B. K. R., I. S. Aaberge, M. Løovik, and B. Haneberg. 1999. Intranasal immunization with heat-inactivated Streptococcus pneumoniae protects mice against systemic pneumococcal infection. Infect. Immun. 67:4320-4325.
33. Jara-Perez, J. V., and A. Berber. 2000. Primary prevention of acute respiratory tract infections in children using a bacterial immunostimulant: a double-masked, placebo-controlled clinical trial. Clin. Ther. 22:748-759.
34. Kyd, J.-M., and A. W. Cripps. 1999. Killed whole bacterial cells, a mucosal delivery system for the induction of immunity in the respiratory tract and middle ear: an overview. Vaccine 17:1775-1781.
35. Locht, C. 2000. Live bacterial vectors for intranasal delivery of protective antigens. Pharm. Sci. Technol. Today 3:121-128.
36. Luster, A. D. 1998. Chemokines-hemotactic cytokines that mediate inflammation. N. Engl. J. Med. 338:672-676.
37. Luster, A. D. 2002. The role of chemokines in linking innate and adaptive immunity. Curr. Opin. Immunol. 14:129-135.
38. Lynch, J. P., and F. J. Martinez. 1998. Community-acquired pneumonia. Curr. Opin. Pulm. Med. 4:162-172.
39. - subclasses of dendritic cells direct the development of distinct T helper cells in vivo. J. Exp. Med. 189:587-592.
40. Maüel, J. 1992. Macrophage activation by OM-85 BV. Respiration 59(Suppl. 3):14-18.
41. Maüel, J. 1994. Stimulation of immunoprotective mechanisms by OM-85 BV. Respiration 61(Suppl. 1):8-15.
42. Mazanec, M., J. Nedrud, C. Kaetzel, and M. Lamm. 1993. A three-tiered view of the role of IgA in mucosal defense. Immunol. Today 14:430-435.
43. + T cell-dependent immune deviation resulting in selective suppression of IgE production. J. Exp. Med. 178:889-899.
44. McWilliam, A. S., D. Nelson, J. A. Thomas, and P. G. Holt. 1994. Rapid dendritic cell recruitment is a hallmark of the acute inflammatory response at mucosal surfaces. J. Exp. Med. 179:1331-1336.
45. McWilliam, A. S., S. Napoli, A. M. Marsh, F. L. Pemper, D. J. Nelson, C. L. Pimm, P. A. Stumbles, T. N. C. Wells, and P. G. Holt. 1996. Dendritic cells are recruited into the airway epithelium during the inflammatory response to a broad spectrum of stimuli. J. Exp. Med. 184:2429-2432.
46. Medoff, B. D., A. Sauty, A. M. Tager, J. A. Maclean, R. N. Smith, A. Mathew, J. H. Dufour, and A. D. Luster. 2002. IFN-gamma-inducible protein 10 (CXCL10) contributes to airway hyperreactivity and airway inflammation in a mouse model of asthma. J. Immunol. 168:5278-5286.
47. Murphy, T. F., J. M. Bernstein, D. M. Dryja, A. A. Campagnari, and M. A. Apicella. 1987. Outer membrane protein and lipooligosaccharide analysis of paired nasopharyngeal and middle ear isolates in otitis media due to nontypable Haemophilus influenzae: pathogenetic and epidemiological observations. J. Infect. Dis. 156:723-731.
48. Orcel, B., B. Delclaux, M. Baud, and J. P. Derenne. 1994. Oral immunization with a bacterial extract for protection against acute bronchitis in elderly, institutionalized patients with chronic bronchitis. Eur. Respir. J. 7:446-452.
49. Palma-Carlos, A. G., and M. L. Palma-Carlos. 1990. Immunomodulation with bacterial extracts in respiratory diseases. Lung 168(Suppl.):732-736.
50. Palma-Carlos, A. G., M. L. Palma-Carlos, F. F. Inaeio, and A. Sousa Uva. 1987. Oral immunotherapy with liophilized bacterial lysates in patients with recurrent respiratory tract infections. Int. J. Immunother. 3:123-126.
51. Partidos, C. D. 2000. Intranasal vaccines: forthcoming challenges. Pharm. Sci. Technol. Today 3:273-281.
52. Paupe, J. 1991. Immunotherapy with an oral bacterial extract (OM-85 BV) for upper respiratory infections. Respiration 58:150-154.
53. Rissoan, M.-C., V. Soumeiis, N. Kadowaki, G. Grourard, F. Briere, R. W. Malefyt, and Y.-J. Liu. 1999. Reciprocal control of T helper cell and dendritic cell differentiation. Science 283:1183-1186.
54. Ruah, S. A. 1981. Broncho Vaxom prevents recurrences of respiratory tract infections. Acta Ther. 7:373-377.
55. Ruah, S. B., C. Ruah, A. van Aubel, S. Abel, and U. Elsasser. 2001. Efficacy of a polyvalent bacterial lysate in children with recurrent respiratory tract infections. Adv. Ther. 18:151-162.
56. Sabroe, I., C. M. Lloyd, M. K. B. Whyte, S. K. Dower, T. J. Williams, and J. E. Pease. 2002. Chemokines, innate and adaptive immunity, and respiratory disease. Eur. Respir. J. 19:350-355.
57. Sallusto, F., D. Lenig, C. R. Mackay, and A. Lanzavecchia. 1998. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J. Exp. Med. 187:875-883.
58. Sallusto, F., C. R. Mackay, and A. Lanzavecchia. 2000. The role of chemokine receptors in primary, effector, and memory immune responses. Annu. Rev. Immunol. 18:593-620.
59. Schon-Hegrad, M. A., J. Oliver., P. G. McMenamin, and P. G. Holt. 1991. Studies on the density, distribution, and surface phenotype of intraepithelial class II major histocompatibiity complex antigen (Ia)-bearing dendritic cells in the conducting airways. J. Exp. Med. 173:1345-1356.
60. Sedgwick, J. D., and P. G. Holt. 1985. Induction of IgE-secreting cells and IgE isotype-specific suppressor T cells in the respiratory lymph nodes of rats in response to antigen inhalation. Cell. Immunol. 94:182-194.
61. Sedgwick, J. D., and P. G. Holt. 1986. Induction of IgE-secreting cells in the lymphatic drainage of the lungs of rats following passive antigen inhalation. Int. Arch. Allergy Appl. Immunol. 79:329-331.
62. Sethi, S., and T. F. Murphy. 2001. Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-art review. Clin. Microbiol. Rev. 14:336-363.
63. Sethi, S., K. Muscarella, N. Evans, K. L. Klingman, B. J. B. Grant, and T. F. Murphy. 2000. Airway inflammation and etiology of acute exacerbations of chronic bronchitis. Chest 118:1557-1565.
64. Souto, J. T., J. C. Aliberti, A. P. Campanelli, M. C. Livonesi, C. M. L. Maffei, B. R. Ferreira, L. R. Travassos, R. Martínez, M. A. Rossi, and J. S. Silva. 2003. Chemokine production and leukocyte recruitment to the lungs of Paracoccidioides brasiliensis-infected mice is modulated by IFN-γ. Am. J. Pathol. 163:583-590.
65. Stumbles, P. A., J. A. Thomas, C. L. Pimm, P. T. Lee, T. J. Venaille, S. Proksch, and P. G. Holt. 1998. Resting respiratory tract dendritic cells preferentially stimulate T helper cell type 2 (Th2) responses and require obligatory cytokine signals for induction of Th1 immunity. J. Exp. Med. 188:2019-2031.
66. Stumbles, P. A. 1999. Regulation of T helper differentiation by respiratory tract dendritic cells. Immunol. Cell. Biol. 77:428-433.
67. Stumbles, P. A., D. H. Strickland, C. L. Pimm, S. F. Proksc, A. M. Marsh, A. S. McWilliam, A. Bosco, I. Tobagus, J. A. Thomas, S. Napoli, A. E. I. Proudfoot, T. N. C. Wells, and P. G. Holt. 2001. Regulation of dendritic cell recruitment into resting and inflamed airway epithelium: use of alternative chemokine receptors as a function of inducing stimulus. J. Immunol. 167:228-234.
68. Tielemans, C., K. Gastaldello, C. Husson, A. Marchant, J. P. Delville, J. L. Vanherweghem, and M. Goldman. 1999. Efficacy of oral immunotherapy on respiratory infections in hemodialysis patients: a double blind placebo-controlled study. Clin. Nephrol. 51:153-160.
69. Vermaelen, K. Y., I. Carro-Muino, B. N. Lambrecht, and R. A. Pauwels. 2001. Specific migratory dendritic cells rapidly transport antigen from the airways to the thoracic lymph nodes. J. Exp. Med. 193:51-60.
70. Visweswaraiah, A., L. A. Novotny, E. J. Hjemdahl-Monsen, L. O. Bakaletz, and Y. Thanavala. 2002. Tracking the tissue distribution of marker dye following intranasal delivery in mice and chinchillas: a multifactorial analysis of parameters affecting nasal retention. Vaccine 20:3209-3220.
71. Vollmer, W. M., M. L. Osborne, and A. S. Buist. 1998. 20-year trends in the prevalence of asthma and chronic airflow obstruction in an HMO. Am. J. Respir. Crit. Care Med. 157:1079-1084.
72. Wilkes, D. S., and J. C. Weissler. 1997. Role of dendritic cells and alveolar macrophages in regulating pulmonary B cell function, p. 335-369. In M. F. Lipscomb and S. W. Russel (ed.), Lung macrophages and dendritic cells in health and disease. Marcel Dekker Inc., New York, N.Y.
73. World Health Organization. 1998. W. H. O. meeting on maternal and neonatal pneumococcal immunization. Wkly. Epidemiol. Rec. 73:187-188.
74. Wu, H. Y., M. H. Nahm, Y. Guo, M. W. Russel, and D. E. Briles. 1997. Intranasal immunization of mice with PspA (pneumococcal surface protein A) can prevent intranasal carriage, pulmonary infection, and sepsis with Streptococcus pneumoniae. J. Infect. Dis. 175:839-846.
75. Wybran, J., M. Libin, and L. Schandene. 1989. Activation of natural killer cells and cytokine production in man by bacterial extracts. Immunopharmacol. Immunotoxicol. 11:17-32.
76. Zagar, S., and D. Lofler-Bradzek. 1988. BV in children with rhinosinusitis: a double blind clinical trial. ORL J. Otorhinolaryngol. Relat. Spec. 50:397-404.
77. Zlotnik, A., and O. Yoshie. 2000. Chemokines: a new classification system and their role in immunity. Immunity 12:121-127.
78. Zwijnenburg, P. J. G., M. M. J. Polifliet, S. Florquin, T. K. van den Berg, C. D. Dijkstra, S. J. H. van Deventer, J. J. Roord, T. van der Poll, and A. M. van Furth. 2003. CXC-chemokines KC and macrophage inflammatory protein-2 (MIP-2) synergistically induce leukocyte recruitment to the central nervous system in rats. Immunol. Lett. 85:1-4.